Status:

RECRUITING

Povidone Iodine Efficacy Study

Lead Sponsor:

University of Rochester

Conditions:

Early Childhood Caries

Eligibility:

All Genders

24-71 years

Phase:

PHASE2

Brief Summary

This is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new cavitated ...

Detailed Description

Objectives: Primary: To assess the efficacy of 10% PVPI in children with S-ECC to prevent new cavitated caries lesions that require follow-up restorative/surgical intervention after oral rehabilitat...

Eligibility Criteria

Inclusion

  • Provide signed and dated informed consent/permission form
  • Parents/primary caregivers willing to comply with all study procedures and be available for the duration of the study
  • Male or female, of any race, ethnicity, aged 24 to 71 months and their parents/primary caregivers who are 18 years of age or older or emancipated minors
  • In good general health as evidenced by medical history, per PI, and in compliance with current CDC, NYS Department of Health and URMC COVID-19 guidelines. American Society of Anesthesiologists (ASA) categories will be used; children classified as ASA I and ASA II will be eligible for the study.
  • Diagnosed with Severe-Early Childhood Caries (S-ECC) requiring treatment in the operating room (OR). A diagnosis of S-ECC will be based on the definition in accordance with American Academy of Pediatric Dentistry (AAPD)

Exclusion

  • Having a known allergy or sensitivity to iodine or seafood, red or yellow food coloring, or to tea, including a hypersensitivity to fluoride varnish, or having thyroid disease, as determined by medical history
  • Receiving or having received treatment with another investigational drug within 30 days of the baseline visit (V1)

Key Trial Info

Start Date :

September 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2027

Estimated Enrollment :

246 Patients enrolled

Trial Details

Trial ID

NCT05272254

Start Date

September 15 2022

End Date

May 1 2027

Last Update

December 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Rochester

Rochester, New York, United States, 14620